- ORCID iD
- 0000-0002-7343-4657
Show
Sort by
-
- Journal Article
- A1
- open access
Personalized development of antisense oligonucleotides for exon skipping restores type XVII collagen expression in junctional epidermolysis bullosa
-
Phase 1 dose escalation trial of ipilimumab and stereotactic body radiation therapy in metastatic melanoma
-
Towards the development of a RNAi-based topical treatment for psoriasis : proof-of-concept in a 3D psoriasis skin model
-
Topically applied lipid- and surfactant-based nanoparticles in the treatment of skin disorders
-
In vitro psoriasis models with focus on reconstructed skin models as promising tools in psoriasis research
-
- Journal Article
- A1
- open access
A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma : evaluation of safety and clinical and immunologic response
-
- Journal Article
- A1
- open access
A phase II trial of stereotactic body radiotherapy with concurrent anti-PD1 treatment in metastatic melanoma : evaluation of clinical and immunologic response
-
- Journal Article
- A1
- open access
JAK3 as an emerging target for topical treatment of inflammatory skin diseases
-
Exploring the feasibility of whole blood to identify systemic miRNA biomarkers for patients with moderate-to-severe psoriasis
-
- Journal Article
- A2
- open access
Characterization data on the topical carrier DDC642
-
The many faces of interleukin-17 in inflammatory skin diseases
-
An elastic liposomal formulation for RNAi-based topical treatment of skin disorders: proof-of-concept in the treatment of psoriasis
-
microRNAs in psoriasis: leaders or followers?
-
Topical carrier for the delivery of therapeutic RNAi molecules to human (impaired) skin
-
Systemic immune changes associated with adjuvant interferon-α2b-therapy in stage III melanoma patients: failure at the effector phase?
-
Stromal protein expression in breast cancer is differentially regulated by TGF-β1
-
Characterization of the in vivo immune network of IDO, tryptophan metabolism, PD-L1, and CTLA-4 in circulating immune cells in melanoma
-
- Journal Article
- A1
- open access
Clinical significance of plasmacytoid dendritic cells and myeloid-derived suppressor cells in melanoma
-
Peritumoral indoleamine 2,3-dioxygenase expression in melanoma : an early marker of resistance to immune control?
-
- Journal Article
- A2
- open access
Differential regulation of extracellular matrix protein expression in carcinoma-associated fibroblasts by TGF-β1 regulates cancer cell spreading but not adhesion